|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 209/14 | (2006.01) |
| A61K 31/4045 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2032531 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07784348.0 |
| Date of filing the European patent application | 2007-06-07 | |
| (97) | Date of publication of the European application | 2009-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-10 |
| (46) | Date of publication of the claims translation | 2016-04-25 |
| (86) | Number | PCT/US2007/070558 |
| Date | 2007-06-07 |
| (87) | Number | WO 2007/146715 |
| Date | 2007-12-21 |
| (30) | Number | Date | Country code |
| 804523 P | 2006-06-12 | US | |
| 869993 P | 2006-12-14 | US |
| (72) |
ACEMOGLU, Murat, CH
BAJWA, Joginder, S., US
KARPINSKI, Piotr, US
PAPOUTSAKIS, Dimitris, US
SLADE, Joel, US
STOWASSER, Frank, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-hidroksi-3-[4-[[[2-(2-metil-1H-indol-3-il)etil]amino]metil]fenil]-2E-2-propenamido druskos |
| SALTS OF N-HYDROXY-3-[4-[[[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE |
| Payment date | Validity (years) | Amount | |
| 2019-05-20 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-06-07 |